RXO

C.H. Robinson Worldwide has agreed to acquire RXO in a stock-and-cash transaction valued at $5.8 billion, creating a combined company with an enterprise value of over $25 billion. The deal is expected to generate $300 million in net run-rate cost synergies within two years post-close.